Integer Holdings Corp. (ITGR)
125.34
-0.05
(-0.04%)
USD |
NYSE |
Sep 02, 15:19
Integer Holdings Research and Development Expense (Annual) : 46.35M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 46.35M |
| December 31, 2024 | 50.44M |
| December 31, 2023 | 58.52M |
| December 31, 2022 | 60.92M |
| December 31, 2021 | 51.98M |
| December 31, 2020 | 48.47M |
| December 31, 2019 | 46.53M |
| December 31, 2018 | 48.45M |
| December 31, 2017 | 48.30M |
| December 31, 2016 | 54.49M |
| December 31, 2015 | 52.58M |
| December 31, 2014 | 49.18M |
| December 31, 2013 | 53.53M |
| December 31, 2012 | 51.94M |
| December 31, 2011 | 45.15M |
| Date | Value |
|---|---|
| December 31, 2010 | 45.02M |
| December 31, 2009 | 17.71M |
| December 31, 2008 | 31.44M |
| December 31, 2007 | 37.91M |
| December 31, 2006 | 16.10M |
| December 31, 2005 | 17.07M |
| December 31, 2004 | 15.76M |
| December 31, 2003 | 9.446M |
| December 31, 2002 | 7.156M |
| December 31, 2001 | 12.58M |
| December 31, 2000 | 9.941M |
| December 31, 1999 | 9.339M |
| December 31, 1998 | 12.19M |
| December 31, 1997 | 9.019M |
| December 31, 1996 | 7.951M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Globus Medical, Inc. | 146.94M |
| Integra LifeSciences Holdings Corp. | 34.81M |
| Abbott Laboratories | 2.889B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.27M |